Molecular multitasking: statins lead to more arteries, less plaque
Michael Simons
Angiogenesis Research Center Beth Israel Deaconess
Medical Center RW-453330 Brookline Ave,Boston,
Massachussetts 02215
msimons@caregroup.harvard.edu
Statins, commonly prescribed cholesterol-lowering drugs, have also
been identified as anti-oxidants, anti-inflammatories and now, as angiogenic
agents. Elucidation of the statin signal transduction pathway should reveal
how one class of drugs can have so many activities (pages 1004−1010).
